Mithridion gets orphan drug designation for leading compound
Mithridion, a Madison drug development company, has received orphan drug designation for its leading compound, MCD-386CR.
Blog Content
Subscribe to:
Post Comments (Atom)
It's hard work to look this good baby
PLAY AND GET YOUR GAMES HERE
Short on cash...need to get it to someone in a hurry...click here
No comments:
Post a Comment